<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Beckonert NM</submitter><funding>Universitätsklinikum Bonn</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Endovascular treatment (ET) options for acute stroke due to distal middle cerebral artery occlusions are rapidly evolving, but data on outcome and safety are sparse. We therefore performed an analysis of patients undergoing ET for primary M3 occlusions in routine clinical practice in a nationwide registry.&lt;h4>Methods&lt;/h4>Patients enrolled between 01/20 and 12/21 in the prospective, multicenter German Stroke Registry-Endovascular Treatment (GSR-ET) were screened for mechanical thrombectomy performed for primary M3 occlusion. We analyzed neurological deficit as measured by the National Institute of Health Stroke Scale (NIHSS), symptomatic intracranial hemorrhage (sICH), thrombectomy technique, successful reperfusion (modified Thrombolysis in Cerebral Infarction [mTICI] sco</pubmed_abstract><journal>Neurological research and practice</journal><pagination>36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11256396</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Endovascular treatment of primary M3 occlusion stroke in clinical practice: analysis of the German Stroke Registry.</pubmed_title><pmcid>PMC11256396</pmcid><pubmed_authors>Bode FJ</pubmed_authors><pubmed_authors>Bormann A</pubmed_authors><pubmed_authors>Braun M</pubmed_authors><pubmed_authors>Stogbauer F</pubmed_authors><pubmed_authors>Kellert L</pubmed_authors><pubmed_authors>Nitsch L</pubmed_authors><pubmed_authors>Alegiani AC</pubmed_authors><pubmed_authors>Henn KH</pubmed_authors><pubmed_authors>Deb-Chatterji M</pubmed_authors><pubmed_authors>Weller JM</pubmed_authors><pubmed_authors>Boeckh-Behrens T</pubmed_authors><pubmed_authors>Ludolph A</pubmed_authors><pubmed_authors>Lehnen NC</pubmed_authors><pubmed_authors>Borggrefe J</pubmed_authors><pubmed_authors>Ernemann U</pubmed_authors><pubmed_authors>Hamann GF</pubmed_authors><pubmed_authors>Petzold GC</pubmed_authors><pubmed_authors>Beckonert NM</pubmed_authors><pubmed_authors>Reich A</pubmed_authors><pubmed_authors>Liman J</pubmed_authors><pubmed_authors>Wunderlich S</pubmed_authors><pubmed_authors>Keil F</pubmed_authors><pubmed_authors>Petersen M</pubmed_authors><pubmed_authors>Thomalla G</pubmed_authors><pubmed_authors>Krause LU</pubmed_authors><pubmed_authors>Tiedt S</pubmed_authors><pubmed_authors>Uphaus T</pubmed_authors><pubmed_authors>Nolte C</pubmed_authors><pubmed_authors>Bohner G</pubmed_authors><pubmed_authors>Ernst MS</pubmed_authors><pubmed_authors>Hattingen J</pubmed_authors><pubmed_authors>Dorn F</pubmed_authors><pubmed_authors>Muehl-Benninghaus R</pubmed_authors><pubmed_authors>Riedel C</pubmed_authors><pubmed_authors>Groschel K</pubmed_authors><pubmed_authors>Schafer JH</pubmed_authors><pubmed_authors>Poli S</pubmed_authors><pubmed_authors>Schell M</pubmed_authors><pubmed_authors>Schellinger P</pubmed_authors><pubmed_authors>Rother J</pubmed_authors><pubmed_authors>Eckert B</pubmed_authors><pubmed_authors>Kraemer C</pubmed_authors><pubmed_authors>Trumm C</pubmed_authors><pubmed_authors>Gerloff C</pubmed_authors><pubmed_authors>Berrouschot J</pubmed_authors><pubmed_authors>Siebert E</pubmed_authors><pubmed_authors>GSR-ET investigators</pubmed_authors><pubmed_authors>Fiehler J</pubmed_authors><pubmed_authors>Nikoubashman O</pubmed_authors><pubmed_authors>Zweynert S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Endovascular treatment of primary M3 occlusion stroke in clinical practice: analysis of the German Stroke Registry.</name><description>&lt;h4>Background&lt;/h4>Endovascular treatment (ET) options for acute stroke due to distal middle cerebral artery occlusions are rapidly evolving, but data on outcome and safety are sparse. We therefore performed an analysis of patients undergoing ET for primary M3 occlusions in routine clinical practice in a nationwide registry.&lt;h4>Methods&lt;/h4>Patients enrolled between 01/20 and 12/21 in the prospective, multicenter German Stroke Registry-Endovascular Treatment (GSR-ET) were screened for mechanical thrombectomy performed for primary M3 occlusion. We analyzed neurological deficit as measured by the National Institute of Health Stroke Scale (NIHSS), symptomatic intracranial hemorrhage (sICH), thrombectomy technique, successful reperfusion (modified Thrombolysis in Cerebral Infarction [mTICI] sco</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-02T22:55:04.831Z</modification><creation>2025-04-06T17:11:47.168Z</creation></dates><accession>S-EPMC11256396</accession><cross_references><pubmed>39020409</pubmed><doi>10.1186/s42466-024-00330-7</doi></cross_references></HashMap>